Strategic Acquisition PPS was recently acquired by Alcami Corporation as of January 2024, presenting an opportunity to engage Alcami’s broader client base and leverage cross-sell of PPS GMP warehousing and clinical distribution services to Alcami’s existing pharmaceutical customers on the West Coast.

Small to Mid‑Cvt Focus PPS specializes in GMP warehouse and clinical distribution for small to mid-sized clinical trials, a segment often underserved by larger providers. This suggests a sales angle targeting similarly sized biotech and specialty pharma firms seeking reliable contingency-ready support and accelerated response times.

Geographic & Capabilities Located in Reno, NV with a dedicated GMP facility, mapped climate-controlled storage, and upcoming vapor phase nitrogen, plus ISO-8 clean room for powder dispensing. This combination can be pitched to companies needing compliant, scalable storage and handling for early-stage trials in proximity to West Coast operations.

Expansion Readiness Expansion to include nitrogen storage signals ongoing capacity enhancement. Use this to align with prospects planning dose-formulation, kit assembly, or cold-chain distribution needs, emphasizing PPS’s ability to scale with evolving trial demands.

Integrated Services Facilities include clinical labeling and kit assembly, enabling bundled services from storage to distribution and labeling. This creates a cross-sell proposition to pharma services firms seeking a single-vendor solution to streamline operations and reduce time-to-trial.